Pharmaceutical company says it will expand programs that lower EpiPen costs

NEW YORK -- Mylan, now in the crosshairs over severe price hikes for its EpiPen, says it will expand programs that lower out-of-pocket costs by as much as half.Mylan N.V. said Thursday that the patient cost will be reduced through a savings card that will cover up to $300 for an EpiPen 2-Pak.The company said it's also doubling eligibility for its patient assistance program, which it said will get rid of out-of-pocket costs for uninsured and underinsured patients and families.Patients will also b